THE following companies saw new developments that may affect trading of their shares on Tuesday:

THE following companies saw new developments that may affect trading of their shares on Wednesday:

THE independent financial adviser (IFA) of mainboard-listed Star Pharmaceutical said on Tuesday that the offer price of S$0.45 a share is “fair and reasonable”.

THE Singapore Exchange's (SGX) minimum trading price (MTP) criteria may have claimed another victim.

The executive chairman of Mainboard-listed Star Pharmaceutical, Xu Zhi Bin,  has purchased from executive director Wang Qi a 22.67 per cent stake in the pharmaceutical company for about S$1.5...